# An Asian Study to Assess the Properties and Profile of Ticagrelor in Patients With Stable Coronary Artery Disease

> **NCT01118325** · PHASE2 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 146 (actual)

## Conditions studied

- Stable Coronary Artery Disease

## Interventions

- **DRUG:** ticagrelor
- **DRUG:** clopidogrel

## Key facts

- **NCT ID:** NCT01118325
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 146 (ACTUAL)
- **Last updated:** 2014-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01118325

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01118325, "An Asian Study to Assess the Properties and Profile of Ticagrelor in Patients With Stable Coronary Artery Disease". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01118325. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*